570,556 snapshots · latest May 3, 2026
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
386,223 snapshots · latest Apr 14, 2026
243,880 snapshots · latest Apr 28, 2026
Dear health care professional letter: Albrioza (PDF Version - 124 K) Health Canada posts safety alerts, public health advisories, press releases and other notices from industry as a service to health professionals, consumers, and other interested parties. Although Health Canada…
Canadian Generic Pharmaceutical Association (CGPA): Final record of decisions June 3, 2021 Health Canada, Health Products and Food Branch (HPFB) Bilateral Meeting Program Virtual June 3, 2021 1:00 p.m. to 3:50 p.m. On this page Participants and observers Meeting minutes Next…
Consultation: Notice of intent to amend the regulations to address health product shortages in Canada Current status: Closed Opened from June 25 to July 25, 2024. Health Canada is proposing to amend the Food and Drug Regulations and the Medical Devices Regulations to: help…
Draft guidance on expanded access clinical trials: Closed consultation From: Health Canada Current status: Closed This consultation ran from August 2 to October 31, 2024. Health Canada has published a draft guidance document on expanded access clinical trials. This document…
Groupement provincial de l’industrie du médicament (GPIM): Final record of decisions April 21, 2022 Health Canada, Health Products and Food Branch (HPFB) Bilateral Meeting Program Virtual April 21, 2022 1:00 p.m. to 2:45 p.m. On this page Participants and observers Meeting…
Notice: Multiple additions to the Prescription Drug List (PDL) [2024-08-13] August 13, 2024 Our file number: 24-107297-36 The purpose of this Notice of Amendment is to notify about the addition of capromorelin (veterinary), eplontersen, lebrikizumab, talquetamab, and zilucoplan…
Notice - Release of the final guidance document: “Switching from prescription to non-prescription status” August 14, 2024 Our file number: 24-106412-576 Health Canada is pleased to announce the release of the final version of the guidance document: “Switching from prescription to…
Notice: Publication of the Guidance Document: Certificates of Supplementary Protection August 19, 2024 Our reference number: 24-107332 - 41 Health Canada is pleased to announce an update to the Guidance Document: Certificates of Supplementary Protection . The Office of Patented…
Qualifying notice for Imdelltra (281963) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: E271976 Control Number: 281963 [name of employee removed] [employee title removed] Amgen…
Innovative Medicines Canada (IMC): Final record of decisions May 17, 2022 Health Canada, Health Products and Food Branch (HPFB) Bilateral Meeting Program Virtual May 17, 2022 1:00 p.m. to 3:10 p.m. On this page Participants Meeting minutes Next meeting Participants IMC…
Early release: coverage and features are still expanding.
